“george-golumbeski” Archives

in
Entry Author Date Location
Backed by $50M, Verseau Launches to Reprogram Immune Cells Against Cancer 10/21/19 Boston
Thwarting Opposition, Bristol Gets Shareholder OK for $74B Celgene Buyout 04/12/19 New York
Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More 03/15/19 National
The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski 03/11/19 National
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More 01/11/19 National
Bio Roundup: Brii Does China, Hemophilia Updates, Right to Try & More 05/25/18 National
Ex-Celgene Dealmaker Tom Daniel Charts a New Course Advising Biotechs 10/17/16 New York
Celgene, Versant Shake Again, Cut $30M Deal For Toronto Biotech 04/29/15 New York
In Venture Reinvention, Versant Sees Gains Amid Biotech Boom Times 04/29/15 National
New York’s Life Science Disruptors: The Photos 03/12/14 New York
10 Takeaways From New York’s Life Science Disruptors 03/10/14 New York
See You Tomorrow at New York’s Life Science Disruptors 03/05/14 New York
New York’s Life Science Disruptors on March 6: Here’s the Agenda 02/26/14 New York
East Coast Biotech Roundup: Voyager, Concert, Retrophin, & More 02/14/14 Boston
Eric Schadt, Acorda’s Cohen Join NY’s Life Science Disruptors Lineup 01/30/14 New York
East Coast Biotech Roundup: Enanta, NY Disruptors, Repligen, & More 01/24/14 Boston
Join Us, And New York’s “Life Science Disruptors,” On March 6 01/23/14 New York
Join Us, and Boston’s “Life Science Disruptors,” on Oct. 2 08/21/13 Boston
East Coast Life Sciences Roundup: Celgene, Dunsire, Forma, & More 07/12/13 Boston
Trusting Your Partners: A Chat With Celgene’s George Golumbeski 07/11/13 New York
Page 1 of 1